Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19.
Journal Information
Full Title: Acta Pharmacol Sin
Abbreviation: Acta Pharmacol Sin
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests The authors declare no competing interests."
Funding Disclosure
Evidence found in paper:
"This work was partially supported by Ministry of Science and Technology (China) grants (2018YFA0507002 to HEX); the Shanghai Municipal Science and Technology Major Project (2019SHZDZX02 to HEX); the CAS Strategic Priority Research Program (XDB08020303 to HEX); the National Natural Science Foundation of China (31770796 to YJ); the Youth Innovation Promotion Association of CAS (No. 2021278 to WCY)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025